Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) closed at $4.41 in the last session, up 2.32% from day before closing price of $4.31. In other words, the price has increased by $2.32 from its previous closing price. On the day, 4.12 million shares were traded. XERS stock price reached its highest trading level at $4.5401 during the session, while it also had its lowest trading level at $4.3.
Ratios:
We take a closer look at XERS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.67.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 20 ’25 when Hecht Beth sold 40,000 shares for $5.43 per share. The transaction valued at 217,244 led to the insider holds 1,353,510 shares of the business.
Hecht Beth bought 40,000 shares of XERS for $205,600 on Mar 20 ’25. On Aug 12 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 4,515 shares for $2.25 each. As a result, the insider paid 10,147 and bolstered with 25,200 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 689657792 and an Enterprise Value of 878702016. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.34. Its current Enterprise Value per Revenue stands at 4.327 whereas that against EBITDA is -56.778.
Stock Price History:
The Beta on a monthly basis for XERS is 0.94, which has changed by 1.52 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $6.07, while it has fallen to a 52-week low of $1.69. The 50-Day Moving Average of the stock is -1.60%, while the 200-Day Moving Average is calculated to be 29.70%.
Shares Statistics:
According to the various share statistics, XERS traded on average about 2.99M shares per day over the past 3-months and 2149790 shares per day over the past 10 days. A total of 149.43M shares are outstanding, with a floating share count of 141.94M. Insiders hold about 7.80% of the company’s shares, while institutions hold 42.82% stake in the company. Shares short for XERS as of 1744675200 were 19050282 with a Short Ratio of 6.38, compared to 1741910400 on 11209763. Therefore, it implies a Short% of Shares Outstanding of 19050282 and a Short% of Float of 12.690000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
